CLINICAL_TRIALS
trial_result
· 2016-07-15
Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) [Phase 2]
Summary
A Phase 2 study (Taski-3) evaluating the efficacy and safety of R935788 tablets in rheumatoid arthritis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigel Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-07-15